MENLO PARK, Calif. (AP) _ Pacific Biosciences of California Inc. (PACB) on Monday reported a loss of $30.8 million in its fourth quarter.
The Menlo Park, California-based company said it had a loss of 21 cents per share.
The maker of genetic analysis technology posted revenue of $19.5 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $21.1 million.
For the year, the company reported that its loss widened to $102.6 million, or 76 cents per share. Revenue was reported as $78.6 million.
Pacific Biosciences shares have declined 3 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $7.17, nearly tripling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PACB at https://www.zacks.com/ap/PACB